Skip to content

Globus Medical

US · GMED #1454 by market cap Listed 1970
66.89 -1.71 -2.49%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 19 in the most recent period (2026/Q3).
  • Total institutional ownership rose 6.5 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
96.56% +6.46pp
Institutions
721 +19
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund81.05%
Individual/Insider17.41%
Hedge Fund6.55%
Public Company4.21%
Government Pension Fund1.77%
Private Company1.07%
Sovereign Wealth Fund0.86%
Insurance Company0.59%
VC/PE Fund0.20%

Top holders as of 2026-03-31

David Paul 16.85% · 22.32M sh
BlackRock 8.23% · 10.91M sh
Janus Henderson Group plc 6.19% · 8.20M sh
Vanguard Capital Management, LLC 3.83% · 5.08M sh
Vanguard Portfolio Management, LLC 3.67% · 4.87M sh
Kayne Anderson Rudnick Investment Management, LLC 3.23% · 4.28M sh
Invesco Ltd. 3.07% · 4.07M sh
State Street Global Advisors 2.81% · 3.72M sh
Sculptor Capital Management, Inc. 2.23% · 3.00M sh
Boston Partners Global Investors, Inc. 2.58% · 3.42M sh
Swedbank Robur Fonder AB 2.15% · 2.88M sh
Dimensional Fund Advisors 2.27% · 3.01M sh
J.P. Morgan Asset Management, Inc. 1.93% · 2.59M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 28 buys · 21 sells

NameRoleStake
David Paul Co-Founder & Executive Chairperson 16.85%
David Davidar Independent Director 0.51%
Ann Rhoads Independent Director 0.03%
Daniel Wolterman Independent Director 0.02%
Leslie Norwalk Independent Director 0.01%
Robert Douglas Independent Director 0.00%
John DeFord Former Independent Director --
Stephen Zarrilli Independent Director --
James Tobin Independent Director --
Daniel Lemaitre Independent Director --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-09 James Tobin Independent Director Derivative Exercise and Sale -41,666 $43.58–75.68
2026-11-03 Ann Rhoads Independent Director Automatic Disposition -5,000 $85.00
2026-09-14 James Tobin Independent Director Derivative Exercise and Sale -30,000 $53.75–74.58
2026-08-17 Stephen Zarrilli Independent Director Derivative Exercise and Sale -25,000 $53.27–87.04
2026-07-26 David Davidar Independent Director Other Disposition -2,500 --
2026-06-04 David Davidar Independent Director Derivative Exercise and Sale -25,000 $26.27–80.76
2026-06-03 Ann Rhoads Independent Director Derivative Exercise and Retained +25,000 $26.27
2026-04-13 John DeFord Former Independent Director Intent to Sell (Form 144) -30,000 $93.10
2026-02-24 Kelly Huller General Counsel Derivative Exercise and Sale -20,000 $43.58–94.50
2026-02-11 Kelly Huller General Counsel Derivative Exercise and Sale -10,000 $45.64–87.67
2026-01-20 Ann Rhoads Independent Director Other Derivative Acquisition +15,000 $94.15
2026-01-20 John DeFord Former Independent Director Other Derivative Acquisition +15,000 $94.15
2026-01-20 Stephen Zarrilli Independent Director Other Derivative Acquisition +15,000 $94.15
2026-01-20 James Tobin Independent Director Other Derivative Acquisition +15,000 $94.15
2026-01-20 David Paul Co-Founder & Executive Chairperson Other Derivative Acquisition +100,000 $94.15
2026-01-20 Daniel Wolterman Independent Director Other Derivative Acquisition +15,000 $94.15
2026-01-20 Robert Douglas Independent Director Other Derivative Acquisition +15,000 $94.15
2026-01-20 David Davidar Independent Director Other Derivative Acquisition +15,000 $94.15
2026-01-20 Leslie Norwalk Independent Director Other Derivative Acquisition +15,000 $94.15
2026-01-20 Daniel Lemaitre Independent Director Other Derivative Acquisition +15,000 $94.15

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Globus Medical discussion 0 comments

Add a comment